FINASTERIDE (finasteride) by Gedeon Richter is 5-alpha reductase inhibitors [moa]. Approved for 5-alpha reductase inhibitor [epc]. First approved in 2006.
Drug data last refreshed 20h ago
5-alpha Reductase Inhibitors
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Comparison of Finasteride and Tamsulosin for Treatment of Benign Prostatic Hyperplasia (BPH) (MK-0906A-149 AM2)
Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia
A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Urinary Symptoms
The Use of Finasteride to Reduce Hematuria and Hematospermia Following TRUS Prostate Biopsy
On Label, Randomized, Double-Blind, Placebo-Controlled Trial of Preoperative Finasteride in Patients Undergoing Transurethral Resection of the Prostate (TURP)
Worked on FINASTERIDE at Gedeon Richter? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.